The treatment of ST elevation myocardial infarction

37895

Acute coronary syndrome is the clinical manifestation of the critical phase of coronary artery disease. Based on electrocardiogram (ECG) and biochemical markers it is distinguished from ST-elevation myocardial infarction, non-ST-elevation myocardial infarction, and unstable angina. The common underlying pathophysiology is related to plaque rupture or erosion with subsequent thrombus formation. Treatment of patients presenting with an acute coronary syndrome aims at immediate relief of ischaemia and the prevention of serious adverse events, including death, myocardial reinfarction, and life-threatening arrhythmias. The general management is predominately guided by the ECG and biomarkers. In general, treatment options include antiplatelet therapy, antithrombins, fibrinolytics, percutaneous coronary interventions, and cardiac surgery. In patients with ST-segment elevation rapid and sustained reperfusion of the infarct related artery by primary percutaneous coronary intervention or fibrinolysis improves early and long-term outcome.

127

Acute coronary syndrome , Fibrinolytics , Coronary artery bypass graft surgery , Percutaneous coronary intervention , Reperfusion , Revascularization , ST elevation myocardial infarction

Journal Of Experimental an‎d Clinical Medicine

131

Journal Of Experimental an‎d Clinical Medicine